The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats-Reference-Cited by-同舟云学术

The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats

Published:2015-02 Issue:2 Volume:185 Page:409-419
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Verbeke Len,Farre Ricard,Verbinnen Bert,Covens Kris,Vanuytsel Tim,Verhaegen Jan,Komuta Mina,Roskams Tania,Chatterjee Sagnik,Annaert Pieter,Elst Ingrid Vander,Windmolders Petra,Trebicka Jonel,Nevens Frederik,Laleman Wim

Funder

Scientific Research–Flanders

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference53 articles.

1. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model;Berg;Infect Immun,1979

2. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites;Garcia-Tsao;Gastroenterology,1995

3. Bacterial translocation in acute and chronic portal hypertension;Garcia-Tsao;Hepatology,1993

4. Bacterial translocation in cirrhotic rats. Its role in the development of spontaneous bacterial peritonitis;Llovet;Gut,1994

5. Bacterial translocation of enteric organisms in patients with cirrhosis;Cirera;J Hepatol,2001

Cited by 164 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interplay between Bile Acids and Intestinal Microbiota: Regulatory Mechanisms and Therapeutic Potential for Infections;Pathogens;2024-08-20

2. Infektionen und Leberzirrhose;Medizinische Klinik - Intensivmedizin und Notfallmedizin;2024-08-09

3. Suppressing FXR promotes antiviral effects of bile acids via enhancing the interferon transcription;Acta Pharmaceutica Sinica B;2024-08

4. Infections in cirrhosis;The Lancet Gastroenterology & Hepatology;2024-08

5. Gut microbiota and metabolites of cirrhotic portal hypertension: a novel target on the therapeutic regulation;Journal of Gastroenterology;2024-07-19